HHLR ADVISORS, LTD. - Q2 2023 holdings

$4.7 Billion is the total value of HHLR ADVISORS, LTD.'s 60 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 42.9% .

 Value Shares↓ Weighting
BGNE SellBEIGENE LTDsponsored adr$923,042,340
-21.7%
5,176,906
-5.4%
19.66%
-6.0%
PDD SellPDD HOLDINGS INCsponsored ads$565,029,158
-30.1%
8,172,247
-23.2%
12.03%
-16.0%
BEKE BuyKE HLDGS INCsponsored ads$531,966,412
-9.6%
35,822,654
+14.7%
11.33%
+8.6%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$444,313,873
+79.6%
6,436,533
+25.5%
9.46%
+115.7%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$271,931,625
-29.7%
3,262,527
-13.8%
5.79%
-15.5%
MSFT BuyMICROSOFT CORP$258,572,022
+249.1%
759,300
+195.6%
5.51%
+319.3%
CRM SellSALESFORCE INC$226,584,167
-34.5%
1,072,537
-38.0%
4.82%
-21.3%
DASH SellDOORDASH INCcl a$203,794,028
-28.0%
2,666,763
-40.1%
4.34%
-13.5%
HTHT BuyH WORLD GROUP LTDsponsored ads$147,918,748
-10.1%
3,814,305
+13.6%
3.15%
+8.0%
TTWO NewTAKE-TWO INTERACTIVE SOFTWAR$115,226,280783,000
+100.0%
2.45%
JD BuyJD.COM INCspon adr cl a$92,294,346
-12.3%
2,704,200
+12.8%
1.96%
+5.3%
DQ  DAQO NEW ENERGY CORPspnsrd ads new$80,868,900
-15.2%
2,037,0000.0%1.72%
+1.8%
BIDU BuyBAIDU INCspon adr rep a$75,759,559
+23.7%
553,353
+36.3%
1.61%
+48.5%
SellON HLDG AGnamen akt a$69,841,992
-31.6%
2,116,424
-35.7%
1.49%
-17.9%
ZTO BuyZTO EXPRESS CAYMAN INCsponsored ads a$62,635,143
+407.7%
2,497,414
+480.1%
1.33%
+509.1%
SellCYTEK BIOSCIENCES INC$56,851,036
-19.7%
6,657,030
-13.6%
1.21%
-3.5%
 ENFUSION INCcl a$55,821,553
+6.9%
4,975,1830.0%1.19%
+28.4%
BBIO SellBRIDGEBIO PHARMA INC$51,487,288
-21.9%
2,993,447
-24.8%
1.10%
-6.3%
CPNG SellCOUPANG INCcl a$49,034,940
-5.5%
2,818,100
-13.1%
1.04%
+13.5%
MDLZ SellMONDELEZ INTL INCcl a$38,205,097
-48.8%
523,788
-51.1%
0.81%
-38.5%
YSG  YATSEN HLDG LTDads$35,288,592
-31.8%
34,939,2000.0%0.75%
-18.1%
YMM SellFULL TRUCK ALLIANCE CO LTDsponsored ads$32,508,326
-23.6%
5,226,419
-6.6%
0.69%
-8.3%
TMO BuyTHERMO FISHER SCIENTIFIC INC$21,627,581
+45.4%
41,452
+60.7%
0.46%
+74.6%
DDOG  DATADOG INC$21,456,678
+35.4%
218,1000.0%0.46%
+62.6%
IMAB SellI MABsponsored ads$20,658,568
-14.1%
6,909,220
-0.7%
0.44%
+3.0%
DHR NewDANAHER CORPORATION$20,520,00085,500
+100.0%
0.44%
BMRN SellBIOMARIN PHARMACEUTICAL INC$19,844,693
-33.9%
228,942
-25.8%
0.42%
-20.5%
EXAS BuyEXACT SCIENCES CORP$18,582,247
+61.1%
197,894
+16.3%
0.40%
+93.2%
KDP NewKEURIG DR PEPPER INC$17,654,041564,568
+100.0%
0.38%
FUTU  FUTU HLDGS LTDspon ads cl a$16,579,011
-23.4%
417,1870.0%0.35%
-8.1%
NTES  NETEASE INCsponsored ads$14,474,493
+9.3%
149,7000.0%0.31%
+31.1%
ADBE NewADOBE SYSTEMS INCORPORATED$13,202,73027,000
+100.0%
0.28%
AKRO SellAKERO THERAPEUTICS INC$12,746,463
+12.7%
273,002
-7.6%
0.27%
+35.5%
GOOG NewALPHABET INCcap stk cl c$12,097,000100,000
+100.0%
0.26%
BuyATOUR LIFESTYLE HOLDINGS LTDsponsored ads$10,743,117
-14.2%
661,522
+38.4%
0.23%
+3.2%
KNSA SellKINIKSA PHARMACEUTICALS LTD$9,838,273
-10.2%
698,741
-31.4%
0.21%
+8.2%
SOHU  SOHU COM LTDsponsored ads$8,064,436
-25.2%
731,8000.0%0.17%
-9.9%
ARGX NewARGENX SEsponsored adr$7,274,31018,665
+100.0%
0.16%
AXSM NewAXSOME THERAPEUTICS INC$7,186,000100,000
+100.0%
0.15%
COIN NewCOINBASE GLOBAL INC$7,155,000100,000
+100.0%
0.15%
LI SellLI AUTO INCsponsored ads$5,991,710
-76.7%
170,704
-83.4%
0.13%
-71.9%
GOSS  GOSSAMER BIO INC$5,968,849
-4.8%
4,974,0410.0%0.13%
+14.4%
NewROIVANT SCIENCES LTD$5,276,487523,461
+100.0%
0.11%
AMD SellADVANCED MICRO DEVICES INC$4,613,355
-58.4%
40,500
-64.2%
0.10%
-50.3%
EM SellSMART SH GLOBAL LTDads$3,850,958
-11.8%
3,949,700
-1.4%
0.08%
+6.5%
VIPS SellVIPSHOP HOLDINGS LIMITEDsponsored ads a$3,276,900
-90.6%
198,600
-91.4%
0.07%
-88.7%
AMZN SellAMAZON COM INC$3,167,748
-68.4%
24,300
-74.9%
0.07%
-62.4%
TUYA  TUYA INCsponsered ads$3,023,4330.0%1,599,7000.0%0.06%
+18.5%
ALGS  ALIGOS THERAPEUTICS INC$2,242,781
+11.1%
2,309,7640.0%0.05%
+33.3%
 MOGU INCspon ads$2,034,024
-26.2%
847,5100.0%0.04%
-12.2%
BZ SellKANZHUN LIMITEDsponsored ads$1,851,150
-55.3%
123,000
-43.5%
0.04%
-46.6%
SellBRIGHT SCHOLAR ED HLDGS LTDspon ads new$1,122,139
-53.1%
993,043
-0.3%
0.02%
-42.9%
 YS BIOPHARMA CO LTDordinary shares$1,037,470
-13.8%
751,7900.0%0.02%
+4.8%
SellPYXIS ONCOLOGY INC$979,471
-54.0%
382,606
-27.9%
0.02%
-44.7%
PLTK SellPLAYTIKA HLDG CORP$844,480
-97.6%
72,800
-97.6%
0.02%
-97.1%
IQ SellIQIYI INCsponsored ads$760,950
-39.3%
142,500
-17.3%
0.02%
-27.3%
HOOK NewHOOKIPA PHARMA INC$678,231770,717
+100.0%
0.01%
 UXIN LTDspon ads new$314,163
-26.8%
191,5630.0%0.01%
-12.5%
 CHINA JO-JO DRUGSTORES INC$161,293
-91.1%
403,3340.0%0.00%
-90.6%
SellSURROZEN INC*w exp 08/01/203$21,370
-12.4%
387,133
-3.2%
0.00%
DLO ExitDLOCAL LTD$0-6,800
-100.0%
-0.00%
ExitROOT INCcl a new$0-138,977
-100.0%
-0.01%
SRPT ExitSAREPTA THERAPEUTICS INC$0-10,404
-100.0%
-0.02%
ExitCCC INTELLIGENT SOLUTIONS HL$0-200,000
-100.0%
-0.03%
PATH ExitUIPATH INCcl a$0-145,200
-100.0%
-0.04%
YY ExitJOYY INC$0-96,500
-100.0%
-0.05%
MNSO ExitMINISO GROUP HLDG LTDsponsored ads$0-242,700
-100.0%
-0.08%
ExitWOLFSPEED INC$0-70,000
-100.0%
-0.08%
DYN ExitDYNE THERAPEUTICS INC$0-478,401
-100.0%
-0.10%
TMF ExitDIREXION SHS ETF TR20yr tres bull$0-793,050
-100.0%
-0.12%
SGEN ExitSEAGEN INC$0-38,350
-100.0%
-0.14%
SNOW ExitSNOWFLAKE INCcl a$0-55,700
-100.0%
-0.15%
REGN ExitREGENERON PHARMACEUTICALS$0-12,500
-100.0%
-0.18%
SNY ExitSANOFIsponsored adr$0-205,700
-100.0%
-0.20%
CTLT ExitCATALENT INC$0-187,000
-100.0%
-0.22%
TLT ExitISHARES TR20 yr tr bd etf$0-195,100
-100.0%
-0.37%
MLCO ExitMELCO RESORTS AND ENTMNT LTDadr$0-1,698,877
-100.0%
-0.38%
ZM ExitZOOM VIDEO COMMUNICATIONS INcl a$0-405,600
-100.0%
-0.53%
UBER ExitUBER TECHNOLOGIES INC$0-1,314,000
-100.0%
-0.74%
FCX ExitFREEPORT-MCMORAN INCcl b$0-6,274,800
-100.0%
-4.55%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings